$0.62
-0.02 (-2.88%)
Open$0.63
Previous Close$0.64
Day High$0.64
Day Low$0.60
52W High$2.54
52W Low$0.16
Volume—
Avg Volume3.79M
Market Cap157.19M
P/E Ratio—
EPS$-0.87
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+5,499.7% upside
Current
$0.62
$0.62
Target
$34.78
$34.78
$27.07
$34.78 avg
$51.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.98M | 12.95M | 5.83M |
| Net Income | -440,979,170 | -514,962,051 | -1,267,217 |
| Profit Margin | -4,416.2% | -4,195.4% | -21.7% |
| EBITDA | -472,909,602 | -582,929,962 | -1,820,131 |
| Free Cash Flow | — | — | -1,133,887 |
| Rev Growth | -22.9% | -22.9% | +8.5% |
| Debt/Equity | 1.25 | 1.25 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |